ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,671.77
0.28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Addex Therapeutics Ltd (ADXN) Share Price

ADXN Addex Therapeutics Ltd

8.60
-0.04 (-0.46%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Addex Therapeutics Ltd NASDAQ:ADXN NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.04 -0.46 8.60 3.44 27.00 8.93 8.39 8.93 659 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.61M -10.56M -0.0573 -17.28 182.51M
 Type  Size  Price  Time  Units 
 13 123 8.60 20:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ADXN News
31/05/202406:00GLOBEAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
08/05/202406:00GLOBEAddex to Present at Bio€quity Europe 2024
29/04/202406:00GLOBEAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
19/04/202406:00GLOBEAddex to Present at the Swiss Biotech Day 2024
18/04/202406:00GLOBEAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
11/04/202406:00GLOBEAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
03/04/202406:00GLOBEAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Period
Draw mode
Data Downloads for ADXN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Addex Therapeutics Ltd Articles